156
U N I T 1
Cell and Tissue Function
R E F E R E N C E S
1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013.
CA Cancer J Clin
. 2013;63:71–81.
2. Striker TP, Kumanr V. Neoplasia. In: Kumar V, Abbas A, Fausto
N, et al.
Robbins and Cotran Pathologic Basis of Disease
. 8th ed.
Philadelphia, PA: Saunders Elsevier; 2010:259–330.
3. Strayer DS, Rubin E, et al. Neoplasia. In: Rubin R, Strayer
DS, eds.
Rubin’s Pathology: Clinicopathologic Foundations of
Medicine
. 6th ed. Philadelphia, PA: Wolters Kluwer Health |
Lippincott Williams & Wilkins; 2012:157–212.
4. Janssen A, Medema RH. Genetic instability: tipping the balance.
Oncogene
. 2013;32:4459–4470.
5. Alberts B, Johnson A, Lewis J, et al.
The Cell
. 5th ed. New York,
NY: Garland Science; 2008:1133–1139, 1175–1176, 1230–1240.
6. Wang L. Molecular signaling regulating anchorage-independence
growth in cancer cells.
Mt Sinai J Med.
2004;71(6):361–367.
7. Carruba G, Webber MM, Quader STA, et al. Regulation of cell-
to-cell communication in non-tumorigenic and malignant human
prostate epithelial cells.
Prostate
. 2002;50:73–82.
8. Marutsuka T, Shimada S, Shiomori K, et al. Mechanisms of
peritoneal metastasis after operation for non-serosa-invasive
gastric carcinoma: an ultrarapid detection system for intra
peritoneal free cancer cells and a prophylactic strategy for
peritoneal metastasis.
Clin Cancer Res
. 2003;9:678–685.
9. Tobler NE, Detmar M. Tumor and lymph node
lymphangiogenesis—Impact on cancer metastasis.
J Leukoc Biol
.
2006;8:691–696.
10. Chen SL, Iddings DM, Scheri R, et al. Lymphatic mapping and
sentinel node analysis: current concepts and applications.
CA
Cancer J Clin
. 2006;56:292–307.
11. Minn AJ, Massagu
è
J. Molecular biology of cancer: invasion
and metastasis. In: DeVita VT Jr., Lawrence TS, Rosenberg
SA, eds.
Cancer: Principles and Practice of Oncology
. 9th ed.
Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams &
Wilkins; 2011:113–126.
12. Kerbel RS. Angiogenesis.
N Engl J Med
. 2008;358:2039–2049.
13. Harlozinska A. Progress in molecular mechanisms of
tumor metastasis and angiogenesis.
Anticancer Res
.
2005;25:3327–3334.
14. Ruffini PA, Morandi P, Altundag K, et al. Manipulating the
chemokine-chemokine receptor network to treat cancer.
Cancer.
2007;109(12):2392–2404.
15. Kakinuma T, Twang ST. Chemokines, chemokine receptors, and
cancer metastasis.
J Leukoc Biol
. 2006;79:639–651.
16. Crocce CM. Oncogenes and cancer.
N Engl J Med.
2008;358(5):502–511.
17. Zhou BP, Hung MC. Dysregulation of cellular signaling by
HER2/neu in breast cancer.
Semin Oncol.
2003;30(5 Suppl 16):
38–48.
18. Esteller M. Epigenetics in cancer.
N Engl J Med.
2008;358(11):
1148–1159.
19. Baylin SB. DNA methylation and gene silencing in cancer.
Nat
Clin Pract Oncol
. 2005;2:S4–S11.
20. Iorio MV, Croce CM. microRNA involvement in human cancer.
Carcinogenesis.
2012;33(6):1126–1133.
21. Schulze-Bergkamen H, Krammer PH. Apoptosis in cancer—
Implications for therapy.
Semin Oncol
. 2004;31:90–119.
22. Mooi WJ, Peeper DS. Oncogene-induced cell senescence—
Halting the road to cancer.
N Engl J Med.
2006;355(10):
1037–1046.
23. Kerbel RS. Tumor angiogenesis.
N Engl J Med.
2008;358(19):
2039.
24. Boccaccio C, Comoglio PM. Invasive growth: a
MET
-driven
genetic programme for cancer and stem cells.
Nat Rev Cancer
.
2006;6:637–645.
25. Ceschi M, Gutzwiller F, Mody H, et al. Epidemiology and
pathophysiology of obesity as a cause of cancer.
Swiss Med Wkly
.
2007;137:50–56.
26. Finn OJ. Cancer immunology.
N Engl J Med.
2008;358(25):
2704–2715.
27. Burnett FM. Immunologic aspects of malignant disease.
Lancet
1967;1:1171.
28. Michels KB, Willett WC. Etiology of cancer: dietary factors.
In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds.
Cancer:
Principles and Practice of Oncology
. 9th ed. Philadelphia,
PA: Wolters Kluwer Health | Lippincott Williams & Wilkins;
2011:217–226.
29. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated
carcinogenesis.
Nat Rev Cancer
. 2007;7:599–612.
30. Jablon S, Kato H. Studies of the mortality of A-bomb survivors:
5. Radiation dose and mortality, 1950–1970.
Radiat Res
.
1972;50:649–698.
31. Liao JB. Viruses and human cancer.
Yale J Biol Med
. 2006;79:
115–122.
32. Centers for Disease Control and Prevention.
HPV vaccine
information for young women—Fact sheet
. [Online]. Available
at:
women.htm. Accessed September 26, 2013.
33. Cornett PA, Dea TO. Cancer. In: Papadakis MA, McPhee SJ, eds.
Current Medical Diagnosis and Treatment
. 52th ed. New York,
NY: McGraw-Hill; 2013:1593–1663.
34. Knight K, Wade S, Balducci L. Prevalence and outcomes of
anemia in cancer: a systematic review of the literature.
Am J
Med.
2004;116(7A):11S–26S.
35. Hurter B, Bush NJ. Cancer-related anemia: Clinical review and
management update.
Clin J Oncol Nurs.
2007;11(3):349–359.
36. Dicato M, Plawny L, Diederich M. Anemia in cancer.
Ann
Oncol.
2011;27(7):viii,167–172.
37. Pedrazzoli P, Rosti G, Secondino S, et al. Iron supplementation
and erythropoiesis-stimulatory agents in the treatment of cancer
anemia.
Cancer
. 2009;115:1169–1175.
38. Gordon JN, Green SR, Goggin PM. Cancer cachexia.
Q J Med
.
2005;98:779–788.
39. Tisdale MJ. Molecular pathways leading to cancer cachexia.
Physiology (Bethesda).
2005;20:340–348.
40. Bennani-Baita N, Davis MP. Cytokines and cancer anorexia
cachexia syndrome.
Am J Hosp Palliat Care.
2008;25(5):407–441.
41. Wu H, Davis JE, Natavio T. Fatigue and distrupted sleep-wake
patterns in patients with cancer: A shared mechanism.
Clin J
Oncol Nurs.
2012;16(2):E56–E68.
42. Ryan JL, Carroll JK, Ryan EP, et al. Mechanisms of cancer-
related fatigue.
Oncologist.
2007;12(Suppl 1):S1–S22.
43. Wang XS. Pathophysiology of cancer-related fatigue.
Clin J
Oncol Nurs.
2008;12(5 Suppl 1):11–20.
44. Hofman M, Ryan JL, Comar D, et al. Cancer-related fatigue: the
scale of the problem.
Oncologist.
2007;12(Suppl 1):4–10.
45. Barsevick AM, Newhall T, Brown S. Management of cancer-
related fatigue.
Clin J Oncol Nurs.
2008;12(5 Suppl 1):21–25.
46. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach
to diagnosis and treatment.
Mayo Clin Proc.
2012;85(9):
838–854.
47. Boyiadzis M, Lieberman FS, Geskin LJ, et al. Paraneoplastic
syndromes. In: DeVita VT Jr, Lawrence TS, Rosenberg SA,
eds.
Cancer: Principles and Practice of Oncology
. 9th ed.
Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams &
Wilkins; 2011:2220–2238.
48. Dalmau J, Rosenfeld M. Paraneoplastic neurologic syndromes.
In: Abeloff MD, Armitage JO, Niolerhuber JE, et al.
Clinical
Oncology
. 4th ed. London, UK: Elsevier/Churchill Livingston;
2008:767–779.
49. Darnell RB, Posner JB. Paraneoplastic syndromes involving the
nervous system.
N Engl J Med.
2003;349(16):1543–1554.
